Raybalance
San Diego, US · 1 known investors
RayBalance develops a proprietary, non-reformulation platform that treats the subcutaneous injection administration site as a delivery-performance variable to improve absorption predictability without altering a partner's drug product. It targets pharmaceutical companies, biosimilar manufacturers, and medical device companies working on follow-on/biosimilar differentiation, lifecycle strategy, and IV-to-SC transition.
BiotechDeep TechMedical Devices
Investors · 1
Frequently asked questions
- What does Raybalance do?
- RayBalance develops a proprietary, non-reformulation platform that treats the subcutaneous injection administration site as a delivery-performance variable to improve absorption predictability without altering a partner's drug product. It targets pharmaceutical companies, biosimilar manufacturers, and medical device companies working on follow-on/biosimilar differentiation, lifecycle strategy, and IV-to-SC transition.
- Who are Raybalance's investors?
- Raybalance's investors include BioBrit.
- Where is Raybalance headquartered?
- Raybalance is headquartered in San Diego, US.